tirzepatide fibrosis liver A rare case of tirzepatide-induced liver injury The Effect of Tirzepatide on

2008;66(3A):494-9

When joint replacement is possible, fusions are rarely done in the large joints of the elbow, shoulder, hip, and knee because of the importance of their mobility to good function

A newer mechanism does not automatically mean fewer risks

NICE guidance (NG28) recommends GLP-1 receptor agonists as a treatment option for adults with type 2 diabetes when: Triple therapy with metformin and two other oral drugs is not effective, not tolerated or contraindicated The person has a BMI of 35 kg/m or higher (adjust accordingly for people from particular ethnic groups) and specific psychological or other medical problems associated with obesity The person has a BMI lower than 35 kg/m and insulin would have significant occupational implications, or weight loss would benefit other significant obesity-related comorbidities GLP-1 receptor agonists may also be considered in combination with insulin therapy in specialist care settings Beyond glycaemic control, specific GLP-1 receptor agonists offer significant cardiovascular benefits